Preoperative therapies for resectable and borderline resectable pancreatic cancer

Journal of Gastrointestinal Oncology, 08/19/2011

Preoperative management of pancreatic cancer is animportant and evolving eld especially with the enlargingdefinition of borderline resectability. Clearly this effort needs a multidisciplinary working group of surgeons,radiation and medical oncologists, gastroenterologists,radiologists and a pathologist committed to researchdriven patient care and is best suited to a high volume center with surgical expertise in vascular resections and interposition grafting. This is important going forward since it may have an impact on sequencing of therapies (chemotherapy, chemoradiation) and can help select patients for specific therapies and for surgery.

Print Article Summary Cat 2 CME Report